Chang Ho Ahn
Direktor/Vorstandsmitglied bei TheraTarget, Inc.
Aktive Positionen von Chang Ho Ahn
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
TheraTarget, Inc.
 TheraTarget, Inc. Pharmaceuticals: MajorHealth Technology TheraTarget, Inc. develops innovative polymer therapeutics for the treatment of cancer. It is a biopharmaceutical drug delivery company developing a variety of polymer-drug conjugates utilizing our nanopolymer drug delivery technologies. The company was founded in October 2008 and is headquartered in Salt Lake, UT. | Direktor/Vorstandsmitglied | - | - |
Karriereverlauf von Chang Ho Ahn
Ehemalige bekannte Positionen von Chang Ho Ahn
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| REXAHN PHARMACEUTICALS, INC. | Direktor/Vorstandsmitglied | 22.06.2015 | 31.08.2017 |
| Vorsitzender | 01.05.2005 | 22.06.2015 | |
| Technik-/Wissenschafts-/F&E-Leiter | 08.03.2011 | - | |
| Gründer | 19.03.2001 | 31.08.2017 | |
| Präsident | 01.05.2005 | 05.02.2013 | |
| Rexahn Corp. | Vorstandsvorsitzender | 01.03.2001 | 01.05.2005 |
| Vorsitzender | 01.03.2001 | 01.05.2005 | |
| The Society of Biomedical Research | Präsident | 01.01.2000 | 01.01.2003 |
| Center for Drug Evaluation & Research | Corporate Officer/Principal | 01.01.1988 | 01.01.2001 |
Ausbildung von Chang Ho Ahn
| The Ohio State University | Doctorate Degree |
| Creighton University | Undergraduate Degree |
| Seoul National University | Undergraduate Degree |
Statistik
International
| Vereinigte Staaten | 8 |
| Südkorea | 2 |
Operativ
| Director/Board Member | 2 |
| Chairman | 2 |
| President | 2 |
Sektoral
| Consumer Services | 4 |
| Health Technology | 3 |
| Government | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Private Unternehmen | 5 |
|---|---|
Rexahn Pharmaceuticals, Inc.
 Rexahn Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Rexahn Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which engages in the research and development of oncology therapeutics. Its drug candidates include the following: RX-31171 for pancreatic, bladder, colon, and lung cancer; and RX-5902 for metastatic triple negative breast cancer. The company was founded by Chang Ho Ahn on March 19, 2001 and is headquartered in Rockville, MD. | Health Technology |
| The Society of Biomedical Research | |
| Center for Drug Evaluation & Research | Government |
| Rexahn Corp. | Finance |
TheraTarget, Inc.
TheraTarget, Inc. Pharmaceuticals: MajorHealth Technology TheraTarget, Inc. develops innovative polymer therapeutics for the treatment of cancer. It is a biopharmaceutical drug delivery company developing a variety of polymer-drug conjugates utilizing our nanopolymer drug delivery technologies. The company was founded in October 2008 and is headquartered in Salt Lake, UT. | Health Technology |
- Börse
- Insiders
- Chang Ho Ahn
- Erfahrung
